Catalyst Wire Dossier Catalyst Wire Dossier

LV232

· Vigonvita Life Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LV232, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers [Phase 1]

See pricing